During the past decade, Institute for Respiratory and Sleep Medicine conducted 0 clinical trials. In the 10-year time frame, 0 clinical trials started and 1 clinical trials were completed, i.e. on average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

In terms of collaborators to trials, out of the total clinical trials conducted in "Institute for Respiratory and Sleep Medicine" #1 collaborator was "Canadian Heart Research Centre" with 1 trials as a collaborator and "Centers for Medicare and Medicaid Services" with 1 trials as a collaborator. Other collaborators include -2 different institutions and companies that were collaborators in the rest 2 trials.

According to Clinical.Site data, the most researched conditions in "Institute for Respiratory and Sleep Medicine" are "Chronic Obstructive Pulmonary Disease" (1 trials) and "Pulmonary Arterial Hypertension" (1 trials). Many other conditions were trialed in "Institute for Respiratory and Sleep Medicine" in a lesser frequency.

Most popular intervention types in "Institute for Respiratory and Sleep Medicine" are "Drug" (2 trials). Other intervention types were less common.

The name of intervention was led by "Supplemental oxygen therapy" (1 trials) and "observational study with patients treated with Tracleer, Ventavis, Veletri, Opsumit and/or Uptravi" (1 trials). Other intervention names were less common.

The vast majority of trials in "Institute for Respiratory and Sleep Medicine" are 2 trials for "All" genders.

Currently, there are NaN active trials in "Institute for Respiratory and Sleep Medicine". undefined are not yet recruiting, undefined are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 2 completed trials in Institute for Respiratory and Sleep Medicine, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Institute for Respiratory and Sleep Medicine, 0 "Phase 1" clinical trials were conducted, 0 "Phase 2" clinical trials and 1 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".